Related Experiment Video
Updated: Jan 19, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Hyperparathyroidism during pregnancy. Is it a diagnostic and therapeutic challenge?
Ansony R Godínez-Vidal1, Édgar Montes de Oca-Durán1, Vania I Aguirre-Rojano1
1Departamento de Cirugía General, Hospital General de México "Dr. Eduardo Liceaga", Ciudad de México, México.
Background:
Primary hyperparathyroidism (PHPT) is characterized by an increase in parathyroid hormone (PTH) and hypercalcemia, which, when present during pregnancy, increases both maternal and fetal morbidity and mortality.
Objective:
Emphasize the importance of surgical intervention in primary hyperparathyroidism during pregnancy.
Clinical Case:
A 27-year-old female with a pregnancy of 27.2 weeks of gestation, with a diagnosis of symptomatic primary hyperparathyroidism secondary to parathyroid adenoma, a history of nephrolithiasis and severe acute pancreatitis, surgery was decided upon finding intrathyroid right parathyroid adenoma, post-surgical course with adequate evolution and remission of hyperparathyroidism.
Conclusions:
Parathyroidectomy in primary hyperparathyroidism during pregnancy is safe.
More Related Videos
Related Concept Videos
17:16Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
04:11High-frequency Ultrasonography Based Early Pregnancy Characterization: A Technique to Study Embryo Implantation and Pregnancy Progression in Pregnant Murine Model
07:59Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:04A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
04:08Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

